We are proud to announce that OMF has funded the establishment of a third ME/CFS Collaborative Research Center, at Uppsala University in Sweden.
The new Uppsala Center will be led by OMF Scientific Advisory Board member Jonas Bergquist, MD, PhD and will work synergistically with the ME/CFS Collaborative Research Center at Stanford led by Ronald W. Davis, PhD, and the ME/CFS Collaborative Research Center at Massachusetts General Hospital and Harvard Affiliated Hospitals, led by Ronald G. Tompkins, MD, ScD, and Wenzhong Xiao, PhD, of Harvard University. All science funded by OMF continues to be under the overall direction of our Scientific Advisory Board, directed by Ron Davis.
This new Collaborative Center focuses on the targeted molecular diagnosis of ME/CFS with the goal of evidence-based strategies for interventions. In Uppsala, significant efforts are being brought to bear on the analysis of cerebrospinal fluid as a unique source of neurochemical biomarkers of ME/CFS. High-resolution mass spectrometry will be used for extremely sensitive detection of endogenous biomolecules. This unique technology, in combination with the development of clinically relevant screening and targeted methods for sampling, will deliver previously unattainable insights into the pathophysiology of ME/CFS.